Article
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood - 21 Jun 2018
Patel Sanjay S, Kuo Frank C, Gibson Christopher J, Steensma David P, Soiffer Robert J, Alyea Edwin P, Chen Yi-Bin A, Fathi Amir T, Graubert Timothy A, Brunner Andrew M, Wadleigh Martha, Stone Richard M, DeAngelo Daniel J, Nardi Valentina, Hasserjian Robert P, Weinberg Olga K
Abstract excerpt
Acute myeloid leukemia (AML) with mutated NPM1 is a newly recognized separate entity in the revised 2016 World Health Organization classification and is associated with a favorable prognosis. Although previous studies have evaluated NPM1 in a binary fashion, little is known about the significance of its mutant allele burden at diagnosis, nor has the effect of comutations (other than FLT3) been extensively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
